Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis

Abstract Background In this pooled, post hoc analysis of a phase 2 trial and the phase 3 TEMSO, TOWER, and TENERE clinical trials, long-term efficacy and safety of teriflunomide were assessed in subgroups of patients with relapsing multiple sclerosis (MS) defined by prior treatment status. Methods P...

Full description

Bibliographic Details
Main Authors: Giancarlo Comi, Mark S. Freedman, José E. Meca-Lallana, Patrick Vermersch, Byoung Joon Kim, Alexander Parajeles, Keith R. Edwards, Ralf Gold, Houari Korideck, Jeffrey Chavin, Elizabeth M. Poole, Patricia K. Coyle
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Neurology
Subjects:
Disease-modifying therapy
Multiple sclerosis
Relapse rate
Teriflunomide
Treatment history
Online Access:http://link.springer.com/article/10.1186/s12883-020-01937-4

Internet

http://link.springer.com/article/10.1186/s12883-020-01937-4

Similar Items